Phase 2-3 Design Decreases The Number of Patients Required To Deliver Results

Christina Annunziata, MD, PhD of National Institutes of Health explains how the phase 2-3 design decreases the number of patients required to deliver results of clinical trials. This was recorded at t... Author: SGO2017 Added: 03/17/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts